↓ Skip to main content

A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2016
Altmetric Badge

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma
Published in
Journal for Immunotherapy of Cancer, December 2016
DOI 10.1186/s40425-016-0194-1
Pubmed ID
Authors

Andrew S. Brohl, Nikhil I. Khushalani, Zeynep Eroglu, Joseph Markowitz, Ram Thapa, Y. Ann Chen, Ragini Kudchadkar, Jeffrey S. Weber

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Germany 1 2%
Unknown 42 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 27%
Student > Ph. D. Student 6 14%
Student > Master 4 9%
Unspecified 4 9%
Student > Bachelor 3 7%
Other 6 14%
Unknown 9 20%
Readers by discipline Count As %
Medicine and Dentistry 16 36%
Unspecified 4 9%
Agricultural and Biological Sciences 3 7%
Biochemistry, Genetics and Molecular Biology 3 7%
Immunology and Microbiology 2 5%
Other 5 11%
Unknown 11 25%